Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of BieJiaJianWan for hepatic fibrosis
ChiCTR-OPN-15007013Phase 4Not yet recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Aug 2015
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of biejiajianwan in hepatic fibrosis, sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: hepatic fibrosis. Planned start Aug 2015; status: not yet recruiting.
02
Drugs
biejiajianwan
03
Conditions
hepatic fibrosis
Beyond the preview
Go deeper on ChiCTR-OPN-15007013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15007013.